Optibrium, a developer of software for small molecule drug discovery, today announced it relocated its Headquarters and R&D facilities to Cambridge Innovation Park. Founded in 2009, Optibrium develops new products and researches novel technologies to improve the efficiency and productivity of the drug discovery process.
Optibrium’s move to larger premises at Cambridge Innovation Park is driven by the company’s rapid recent growth and will accommodate future expansion plans as it accelerates its R&D pipeline and extends research into new technologies to improve the efficiency and productivity of the drug discovery process.
Dr Matthew Segall, Optibrium’s CEO, commented: “As we move to larger, custom-designed offices, it is encouraging to see that our ongoing investment in the best scientists and engineers, who deliver cutting-edge features to our users, has resulted in strong revenue growth and thus sets the foundations for further expansion.”
Optibrium are due to move into their new offices within Blenheim House on Cambridge Innovation Park in February.
The Park provides a great environment for software developers and similar tech businesses and encourages sharing and networking amongst its tenants. Cambridge Innovation Park attracts high quality staff with its ‘better working lifestyle’ offering on-site Inspired Health & Fitness Club, Brooke’s Beauty, Soda Wine Bar & Bistro and coming in 2019; Beach Babies Nursery.
For further information on serviced offices view our Office Accommodation page or to read Optibrium’s full press release click HERE.